Company Filing History:
Years Active: 2015
Title: Innovations in Gastric Cancer Diagnosis and Treatment by Shiyan Wang
Introduction
Shiyan Wang is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in the area of gastric cancer. His innovative work focuses on the detection and treatment of this serious disease, showcasing his commitment to advancing healthcare.
Latest Patents
Shiyan Wang holds 1 patent for his invention titled "Biomarker DACT1 for gastric cancer." This patent provides a method for diagnosing and determining the prognosis of gastric cancer in a subject by detecting suppressed expression of the DACT1 gene. In some cases, this suppression is due to elevated methylation levels in the genomic sequence of this gene. The invention also includes a kit and device useful for this diagnostic method. Furthermore, it offers a method for treating gastric cancer by increasing DACT1 gene expression or activity.
Career Highlights
Shiyan Wang is affiliated with The Chinese University of Hong Kong, where he continues to engage in groundbreaking research. His work has the potential to significantly impact the way gastric cancer is diagnosed and treated, providing hope for many patients.
Collaborations
Shiyan Wang collaborates with notable colleagues, including Jun Yu and Joseph Jao Yiu Sung. Their combined expertise enhances the research efforts and innovation in the field of cancer diagnostics.
Conclusion
Shiyan Wang's contributions to gastric cancer research exemplify the importance of innovation in medicine. His patented methods and ongoing work at The Chinese University of Hong Kong are paving the way for improved diagnostic and treatment options for patients suffering from this disease.